www.praktickelekarenstvi.cz e28 PRAKTICKÉ LÉKÁRENSTVÍ AKTUÁLNÍ FARMAKOTERAPIE Lékové interakce antiepileptik Část 2 – interakce s léky z jiných indikačních skupin 19. Eckhardt K, Ammon S, Hofmann U et al. Gabapentin enhances the analgesic effect of morphine in healthy volunteers Anesth Analg. 2000; 91: 185–191. 20. Gélisse P, Hillaire-Buys D, Halaili E et al. Carbamazepine and clarithromycin: a clinically relevant drug interaction. Rev Neurol (Paris). 2007; 163: 1096–1099. 21. Faigle JW, Feldmann KF. Carbamazepine. Chemistry and biotransformation. In Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic Drugs. New York: Raven Press 1995; 499–513. 22. ŠímaM, Hartinger J, Rulíšek J, Šachl R, Slanař O. Meropenem-induced valproic acid elimination: A case report of clinically relevant drug interaction. Prague Medical Report 2017; 118: 105–109. 23. Khobrani MA, Dudley SW, Huckleberry YC, Kopp BJ, Biggs AD, French RNE, Shirazi FM, Erstad BL. Intentional use of carbapenem antibiotics for valproic acid toxicity: A case report. J Clin Pharm Ther. 2018; 43: 723–725. 24. Thomas C, Priano J, Smith TL. Meropenem as an antidote for intentional valproic acid overdose. Am J Emerg Med. 2020; 38: 690e1–690e2. 25. Gidal BE, Maganti R, Laurenza A, Yang Haichen Verbel DA, Schuck E, Ferry J. Effect of enzyme inhibition on perampanel pharmacokinetics: Why study design matters Epilepsy Res. 2017; 134: 41–48. 26. Manitpisitkul P, Curtin CR, Shalayda K, Wang S-S, Ford L, Heald D. Pharmacokinetic interactions between topiramate and diltiazem, hydrochlorothiazide, or propranolol. Clin Pharmacol Drug Dev 2014; 3: 378–387. 27. Blum RA, Wilton JH, Hilligoss DM, Gardner MJ, Henry EB, Harrison NJ, Schentag JJ. Effect of fluconazole on the disposition of phenytoin. Clin Pharmacol Ther. 1991; 49: 420–425. 28. Bullman J, Nicholls A, Van Landingham K, Fleck R, Vuong A, Miller J et al. Effects of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy volunteers. Epilepsia 2011; 52: 1351–1358. 29. Chhun S, Versuyf C, Rizzo-Padoin N, Simoneau G, BEcquemont L, Peretti I et al. Gefitinib-phenytoin interaction is not correlated with the C-erythromycin breath test in healthy male volunteers. Br J Clin Pharmacol. 2009; 68: 226–237. 30. May CA, Garnett WR, Small RE, Pellock RM. Effects of three antacids on the bioavailability of valproic acid. Clin Pharm. 1982; 1: 244–247.
RkJQdWJsaXNoZXIy NDA4Mjc=